MwanzoNATCOPHARM • NSE
add
Natco Pharma Ltd
Bei iliyotangulia
₹ 949.25
Bei za siku
₹ 928.20 - ₹ 945.95
Bei za mwaka
₹ 726.80 - ₹ 1,505.00
Thamani ya kampuni katika soko
167.41B INR
Wastani wa hisa zilizouzwa
2.17M
Uwiano wa bei na mapato
10.88
Mgao wa faida
0.53%
Ubadilishanaji wa msingi
NSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 13.63B | -0.59% |
Matumizi ya uendeshaji wa biashara | 6.66B | 53.22% |
Mapato halisi | 5.18B | -23.46% |
Kiwango cha faida halisi | 38.03 | -23.02% |
Mapato kwa kila hisa | 28.94 | -23.46% |
EBITDA | 5.82B | -27.59% |
Asilimia ya kodi ya mapato | 15.61% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 32.04B | 30.08% |
Jumla ya mali | 104.30B | 26.51% |
Jumla ya dhima | 17.76B | 63.24% |
Jumla ya hisa | 86.54B | — |
hisa zilizosalia | 179.13M | — |
Uwiano wa bei na thamani | 1.97 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 15.67% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 5.18B | -23.46% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1981
Makao Makuu
Tovuti
Wafanyakazi
4,199
